JAN (NYSE:JAN) Given Consensus Rating of “Moderate Buy” by Analysts

Shares of JAN (NYSE:JAN) have earned an average recommendation of “Moderate Buy” from the fifteen analysts that are presently covering the company, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold rating, eleven have given a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among analysts that have issued ratings on the stock in the last year is $31.7143.

JAN has been the topic of several research reports. Cantor Fitzgerald upped their price objective on JAN from $30.00 to $34.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Morgan Stanley boosted their target price on shares of JAN from $28.00 to $31.00 and gave the company an “overweight” rating in a research note on Tuesday, August 18th. Scotiabank increased their price target on JAN from $30.00 to $31.00 and gave the stock an “outperform” rating in a research note on Wednesday, September 2nd. Zacks Research lowered shares of JAN from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, August 11th. Finally, UBS Group set a $29.00 target price on shares of JAN in a report on Thursday, June 18th.

Institutional Investors Weigh In On JAN

Several hedge funds have recently bought and sold shares of the business. Greenland Capital Management LP purchased a new stake in shares of JAN in the second quarter worth approximately $575,000. Readystate Asset Management LP bought a new stake in shares of JAN during the 2nd quarter worth about $1,724,000. WINTON GROUP Ltd bought a new stake in JAN during the second quarter worth approximately $2,985,000. Wellington Management Group LLP acquired a new position in JAN in the 2nd quarter valued at $8,739,000. Finally, Engineers Gate Manager LP acquired a new stake in shares of JAN in the second quarter valued at about $15,274,000. 6.27% of the stock is owned by hedge funds and other institutional investors.

Key Headlines Impacting JAN

Here are the key news stories impacting JAN this week:

• Positive Sentiment: Huntington’s “Outperform” rating and $36 target provide a new positive valuation signal and suggest the analyst sees potential for further appreciation. JAN receives Huntington Outperform rating and $36 price target
• Neutral Sentiment: A recent article about JAN-PRO of San Antonio outlined cleaning requirements for hotels and hospitality. The item may support brand visibility and franchise activity, but it contained no specific financial guidance or material company-wide update. JAN-PRO hospitality cleaning requirements
• Negative Sentiment: Investor sentiment remains constrained by JAN’s latest quarterly earnings miss: adjusted earnings were $0.05 per share versus a $0.23 consensus estimate, even though revenue reached $216.46 million and increased 45.4% year over year. The earnings shortfall may be outweighing the new analyst optimism in the near term.

JAN Price Performance

Shares of JAN stock opened at $30.76 on Friday. JAN has a 1-year low of $22.76 and a 1-year high of $32.83. The firm’s 50-day simple moving average is $30.34.

JAN (NYSE:JAN) last announced its earnings results on Tuesday, August 4th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.18). The business had revenue of $216.46 million during the quarter, compared to the consensus estimate of $203.32 million. The company’s revenue for the quarter was up 45.4% compared to the same quarter last year. JAN has set its FY 2026 guidance at 0.950-0.980 EPS. On average, analysts predict that JAN will post 0.97 EPS for the current fiscal year.

JAN Dividend Announcement

The company also recently declared a monthly dividend, which will be paid on Wednesday, September 23rd. Stockholders of record on Friday, September 11th will be issued a dividend of $0.0475 per share. The ex-dividend date is Friday, September 11th. This represents a c) dividend on an annualized basis and a dividend yield of 1.9%.

About JAN

JanOne Inc is a technology and life sciences company focused on addressing the global opioid crisis. The company’s activities include developing and supporting pharmaceutical and other solutions intended to help reduce opioid-related deaths and dependency.

JanOne has also pursued blockchain and financial technology initiatives through its Alt 5 Sigma operations. These activities have included blockchain-based payment, digital asset and financial services solutions designed to help businesses manage transactions and related digital assets.

The company serves markets through its healthcare, technology and financial services initiatives, with an emphasis on solutions that can be applied internationally.